Paul Armentano

Last updated

Paul Armentano is an American cannabis activist. He is the Deputy Director [1] of NORML. [2] He also serves on the faculty of Oaksterdam University in Oakland, where he is the Chair of Science.

His writing on cannabis and cannabis policy has appeared in over 1,000 publications, scholarly and/or peer-reviewed journals, as well as in more than two dozen textbooks and anthologies. He is a regulator contributor [3] [ dead link ] to The Hill newspaper as well as to numerous other print and online publications. Mr. Armentano is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? (2009, Chelsea Green), which has been licensed and translated internationally. He is also the author of the book The Citizen’s Guide to State-By-State Marijuana Laws (2015), available from Whitman Publishing. He is the author and editor of the NORML-produced publication Emerging Clinical Applications for Cannabis and Cannabinoids, which summarizes over 400 peer-reviewed studies specific to the safety and efficacy of cannabis among different patient populations.

Mr. Armentano was the principal investigator for defense counsel in the federal case US v Schweder et al., one of the first legal cases in decades to challenge [4] the constitutionality of cannabis as a schedule I controlled substance. He was also an expert in the successful Canadian constitutional challenge, Allard v Canada, [5] which preserved qualified patients right to grow cannabis at home.

He is the 2013 Freedom Law School Health Freedom Champion of the Year and the 2013 Alfred R. Lindesmith award recipient in the achievement in the field of scholarship. [6] He is the 2019 Al Horn Memorial Award recipient in appreciation of advancing the cause of justice. [7]

Mr. Armentano works closely with numerous state and federal politicians with regard to drafting and enacting marijuana policy reforms, and he is a frequently sought speaker on the topic at legal and academic seminars.

Related Research Articles

The National Organization for the Reform of Marijuana Laws is a social welfare organization based in Washington, D.C., that advocates for the reform of marijuana laws in the United States regarding both medical and non-medical use. According to their website, NORML supports "the removal of all penalties for the private possession and responsible use of marijuana by adults, including cultivation for personal use, and casual nonprofit transfers of small amounts" and advocates for "the creation of a legal and regulatory framework for marijuana's production and retail sale to adults". NORML also has a sister organization, NORML Foundation, that focuses on educational efforts and providing legal assistance and support to people affected negatively by current marijuana laws. NORML maintains chapters in a number of US states as well as outside the US in countries such as Canada, France, New Zealand, and South Africa.

<span class="mw-page-title-main">Seattle Hempfest</span> Cannabis festival in Seattle, Washington

Seattle Hempfest is an annual event in the city of Seattle, Washington advocating the legalization of cannabis. Vivian McPeak serves as the organization's executive director. Founded in 1991 as the Washington Hemp Expo, a self-described "humble gathering of stoners" attended by only 500 people, and renamed the following year as Hempfest, it has grown into a three-day annual political rally, concert, and arts and crafts fair with attendance typically over 100,000. Speakers have included Seattle city council member Nick Licata, actor/activist Woody Harrelson (2004), travel writer and TV host Rick Steves (2007), (2010), 2012 Green Party speaker Jill Stein, Dallas Cowboys center Mark Stepnoski (2003), and former chief of the Seattle Police Department Norm Stamper (2006). Hempfest has also in recent years attracted such well-known performers as Fishbone (2002), The Kottonmouth Kings (2004), Rehab (2006), and Pato Banton (2007) to its five stages spread throughout Myrtle Edwards Park and Elliott Bay Park, on Seattle's waterfront.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category is the most tightly restricted category reserved for drugs that have "no currently accepted medical use.”

<span class="mw-page-title-main">Steve Kubby</span> United States politician and activist

Steven Wynn "Steve" Kubby was a Libertarian Party activist who played a key role in the drafting and passage of California Proposition 215. The proposition was a ballot initiative to legalize medical marijuana which was approved by voters in 1996. Kubby was known as a cancer patient who relied on medical cannabis. He authored two books on drug policy reform: The Politics of Consciousness (1995) and Why Marijuana Should Be Legal (2003). He was the Libertarian Party of California candidate for Governor of California in 1998 receiving 0.9% of the vote. In 2008, he declared his candidacy for the Libertarian Party's 2008 presidential nomination and received significant support for the nomination, but was eliminated after the second ballot. Although various media reports have described him as a "felon" and "fugitive", Kubby's legal status was resolved on July 3, 2008, when California Superior Court Judge, David Nelson, dismissed all charges against Kubby, clearing his name and record of any criminal activity.

<span class="mw-page-title-main">Legalization of non-medical cannabis in the United States</span> Legalization of marijuana in the United States

In the United States, the non-medical use of cannabis is legalized in 21 states and decriminalized in 10 states, as of January 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.

The American Medical Marijuana Association (AMMA) is an organization formed to promote and protect legal access to medical marijuana.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

<span class="mw-page-title-main">Drug liberalization</span> Process of reducing drug prohibition laws

Drug liberalization is a drug policy process of decriminalizing or legalizing the use or sale of prohibited drugs. Variations of drug liberalization include: drug legalization, drug re-legalization and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

<span class="mw-page-title-main">Medical cannabis in the United States</span> Use of cannabis for medical purposes in the United States

In the United States, the use of cannabis for medical purposes is legal in 37 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of February 2022. Eleven other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

Several authors have put forth arguments concerning the legality of the war on drugs. In his essay The Drug War and the Constitution, libertarian philosopher Paul Hager makes the case that the War on Drugs in the United States is an illegal form of prohibition, which violates the principles of a limited government embodied in the United States Constitution.

<span class="mw-page-title-main">Legality of cannabis by U.S. jurisdiction</span> Cannabis laws by state and territory

In the United States, the use and possession of cannabis is illegal under federal law for any purpose by way of the Controlled Substances Act of 1970 (CSA). Under the CSA, cannabis is classified as a Schedule I substance, determined to have a high potential for abuse and no accepted medical use. Despite this, most states have legalized either or both the medical and recreational use of cannabis.

<span class="mw-page-title-main">Timeline of cannabis laws in the United States</span> Historical list in chronological order of U.S. cannabis law

The legal history of cannabis in the United States began with state-level prohibition in the early 20th century, with the first major federal limitations occurring in 1937. Starting with Oregon in 1973, individual states began to liberalize cannabis laws through decriminalization. In 1996, California became the first state to legalize medical cannabis, sparking a trend that spread to a majority of states by 2016. In 2012, Washington and Colorado became the first states to legalize cannabis for recreational use.

<span class="mw-page-title-main">Burnside Burn</span> 2015 cannabis event in Portland, Oregon

The "Burnside Burn" was an event held on the Burnside Bridge in Portland, Oregon, starting at midnight on July 1, 2015, the day recreational marijuana became legal in the U.S. state of Oregon. It was organized by Portland NORML, the local chapter of the National Organization for the Reform of Marijuana Laws, having originated from its executive director, who wanted to photograph himself in front of the White Stag sign in the moments after Oregon Ballot Measure 91 took effect. The crowd, larger than anticipated, numbered in the thousands and at times blocked traffic lanes on the bridge. Some attendees wanted to commemorate the moment, while others were motivated by announcements of free marijuana and seeds. No fines were issued for consumption in public. The event was covered by cannabis publications, local and national news outlets, and the HBO television series Vice.

<span class="mw-page-title-main">2016 Florida Amendment 2</span> Ballot measure in Florida legalizing medical marijuana

The Florida Medical Marijuana Legalization Initiative, also known as Amendment 2, was approved by voters in the Tuesday, November 8, 2016, general election in the State of Florida. The bill required a super-majority vote to pass, with at least 60% of voters voting for support of a state constitutional amendment. Florida already had a medical marijuana law in place, but only for those who are terminally ill and with less than a year left to live. The goal of Amendment 2 is to alleviate those suffering from these medical conditions: cancer, epilepsy, glaucoma, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn's disease, Parkinson's disease, multiple sclerosis, chronic nonmalignant pain caused by a qualifying medical condition or that originates from a qualified medical condition or other debilitating medical conditions comparable to those listed. Under Amendment 2, the medical marijuana will be given to the patient if the physician believes that the medical use of marijuana would likely outweigh the potential health risks for a patient. Smoking the medication was not allowed under a statute passed by the Florida State Legislature, however this ban was struck down by Leon County Circuit Court Judge Karen Gievers on May 25, 2018.

<span class="mw-page-title-main">Cannabis in Ohio</span> Legality, use and culture of cannabis in the U.S. state of Ohio

Cannabis in Ohio is legal for medical use and illegal for recreational use. Since 1975, possession of up to 100 grams has been decriminalized, with several of the state's major cities having enacted further reforms. Medical use was legalized in 2016 through a bill passed by the state legislature.

<span class="mw-page-title-main">Cannabis in Michigan</span> Legality, use and culture of cannabis in the U.S. state of Michigan

Cannabis in Michigan is legal for recreational use. A 2018 initiative to legalize recreational use passed with 56% of the vote. State-licensed sales of recreational cannabis began in December 2019.

<span class="mw-page-title-main">Cannabis in South Africa</span> Use of cannabis in South Africa

Cannabis in South Africa has been decriminalised by the country's Constitutional Court for personal consumption by adults in private. However, laws prohibiting use outside of one's private dwelling and buying and selling cannabis still remain. Since regulations against the purchase of products containing cannabis still remain in effect, it is unclear how the ruling can be enforced.

<span class="mw-page-title-main">Texas NORML</span>

Texas NORML is a chapter of the National Organization for the Reform of Marijuana Laws (NORML) based in Austin, Texas. Jax Finkel serves as the organization's executive director. The organization's mission is to establish legal access to cannabis for all Texans.

<span class="mw-page-title-main">Cannabis rights</span> Legal protections for marijuana consumers

Cannabis rights or marijuana rights are individual civil and human rights that vary by jurisdiction. The rights of people who consume cannabis include the right to be free from employment discrimination and housing discrimination.

References

  1. "Staff". NORML. Retrieved 2022-09-23.
  2. "About NORML". NORML. Retrieved 2022-09-23.
  3. "Paul Armentano on The Hill".
  4. "United States v. Schweder, Case No. 2:11-cr-00449-KJM | Casetext Search + Citator". casetext.com. Retrieved 2022-09-23.
  5. "Allard v. Canada, 2016 FC 236 (CanLII), [2016] 3 FCR 303". Canlii. Retrieved 2022-09-23.
  6. "Contributor Biography: Paul Armentano". www.icle.org. Retrieved 2022-09-23.
  7. "Paul Armentano". www.amazon.com. Retrieved 2022-09-23.